• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻息肉的内镜分级系统:我们是在进行不恰当的比较吗?

Endoscopic grading systems for nasal polyps: are we comparing apples to oranges?

作者信息

Djupesland P G, Reitsma S, Hopkins C, Sedaghat A R, Peters A, Fokkens W J

机构信息

Optinose AS, Oslo Science Park, Oslo, Norway.

Department of Otorhinolaryngology, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands.

出版信息

Rhinology. 2022 Jun 1;60(3):169-176. doi: 10.4193/Rhin21.401.

DOI:10.4193/Rhin21.401
PMID:35403178
Abstract

Endoscopic grading of nasal polyps (NP) is typically a coprimary endpoint in clinical trials evaluating treatments for chronic rhinosinusitis with nasal polyps (CRSwNP). However, a consensus on the most effective way to grade nasal polyps has not been reached. Different scales have been used, hampering the interpretation of data across trials. This review compares the characteristics of NP grading systems used in registration trials for approved NP treatments. These fundamental differences in grading systems make quantitative comparison of outcomes between trials inaccurate and potentially misleading. In lieu of a universal grading system, reporting the baseline distribution of polyp grades (unilateral and/or summed/total grades), as well as changes from baseline over time by baseline grade may help improve interpretability of outcomes and reduce inaccuracy when attempting cross-trial comparisons and making therapeutic decisions.

摘要

鼻息肉(NP)的内镜分级通常是评估鼻息肉慢性鼻窦炎(CRSwNP)治疗方法的临床试验中的共同主要终点。然而,尚未就鼻息肉最有效的分级方法达成共识。已使用了不同的量表,这妨碍了对各试验数据的解读。本综述比较了已批准的NP治疗注册试验中使用的NP分级系统的特征。分级系统中的这些根本差异使得试验间结果的定量比较不准确且可能产生误导。由于缺乏通用的分级系统,报告息肉分级的基线分布(单侧和/或总和/总分级)以及随时间推移各基线分级相对于基线的变化,可能有助于提高结果的可解释性,并在尝试进行跨试验比较和做出治疗决策时减少不准确之处。

相似文献

1
Endoscopic grading systems for nasal polyps: are we comparing apples to oranges?鼻息肉的内镜分级系统:我们是在进行不恰当的比较吗?
Rhinology. 2022 Jun 1;60(3):169-176. doi: 10.4193/Rhin21.401.
2
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.鼻内用类固醇与安慰剂或不干预治疗慢性鼻-鼻窦炎的比较
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011996. doi: 10.1002/14651858.CD011996.pub2.
3
Saline irrigation for chronic rhinosinusitis.慢性鼻窦炎的盐水冲洗
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011995. doi: 10.1002/14651858.CD011995.pub2.
4
Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.贝那鲁肽治疗伴有鼻息肉的重度慢性鼻-鼻窦炎(CRSwNP)的随机双盲安慰剂对照试验。
Clin Exp Allergy. 2021 Jun;51(6):836-844. doi: 10.1111/cea.13852. Epub 2021 Feb 27.
5
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.奥马珠单抗治疗鼻息肉的疗效和安全性:两项随机 3 期临床试验。
J Allergy Clin Immunol. 2020 Sep;146(3):595-605. doi: 10.1016/j.jaci.2020.05.032. Epub 2020 Jun 7.
6
EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.EXHANCE-3:一项关于使用氟替卡松治疗慢性鼻-鼻窦炎伴或不伴鼻息肉的呼气输送系统的队列研究。
Rhinology. 2020 Feb 1;58(1):25-35. doi: 10.4193/Rhin19.124.
7
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.度普利尤单抗治疗伴有鼻息肉的重度慢性鼻-鼻窦炎患者的疗效和安全性(LIBERTY NP SINUS-24 和 LIBERTY NP SINUS-52):两项多中心、随机、双盲、安慰剂对照、平行分组 3 期临床试验的结果。
Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19.
8
NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.NAVIGATE II 研究:使用氟替卡松经呼气传输系统治疗鼻息肉的随机、双盲试验。
J Allergy Clin Immunol. 2019 Jan;143(1):126-134.e5. doi: 10.1016/j.jaci.2018.06.010. Epub 2018 Jun 19.
9
Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study.鼻息肉患者血清淀粉样蛋白A升高与慢性鼻-鼻窦炎伴鼻息肉患者全身皮质类固醇不敏感性相关:一项初步研究。
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):401-408. doi: 10.1007/s00405-017-4809-z. Epub 2017 Nov 25.
10
Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery.鼻内应用氟替卡松喷雾、布地奈德雾化器和布地奈德混悬液治疗慢性鼻-鼻窦炎鼻息肉内镜鼻窦手术后患者的疗效比较。
Int Forum Allergy Rhinol. 2016 Mar;6(3):233-7. doi: 10.1002/alr.21688. Epub 2015 Dec 17.

引用本文的文献

1
Superior Benefits of Combining Mepolizumab With Sinus Surgery Compared to Mepolizumab Alone: Results From a Randomised 6-Month Trial.与单独使用美泊利单抗相比,美泊利单抗联合鼻窦手术的卓越优势:一项为期6个月的随机试验结果
Int Forum Allergy Rhinol. 2025 Jul;15(7):724-733. doi: 10.1002/alr.23562. Epub 2025 Mar 10.
2
Clinical effectiveness of dupilumab in CRSwNP: unaffected by baseline nasal polyp size in real-world settings.度普利尤单抗治疗慢性鼻-鼻窦炎伴鼻息肉的临床疗效:在现实环境中不受基线鼻息肉大小的影响。
Eur Arch Otorhinolaryngol. 2025 Jun;282(6):3329-3334. doi: 10.1007/s00405-025-09275-2. Epub 2025 Feb 20.
3
Consultation for Chronic Rhinosinusitis With Nasal Polyps and Asthma: Clinical Presentation, Diagnostic Workup, and Treatment Options.
慢性鼻-鼻窦炎伴鼻息肉和哮喘患者的就诊:临床表现、诊断方法和治疗选择。
J Allergy Clin Immunol Pract. 2024 Nov;12(11):2898-2905. doi: 10.1016/j.jaip.2024.07.019. Epub 2024 Jul 30.
4
Comparative short-term efficacy of endoscopic sinus surgery and biological therapies in chronic rhinosinusitis with nasal polyps: A network meta-analysis.内镜鼻窦手术与生物疗法治疗鼻息肉慢性鼻-鼻窦炎的短期疗效比较:网状Meta分析
Clin Transl Allergy. 2023 Jun;13(6):e12269. doi: 10.1002/clt2.12269.